Abstract:Megumi Sumizono, 1, 2 Yushin Yoshizato, 1 Ryohei Yamamoto, 1 Takaki Imai, 1 Akira Tani, 2 Kazuki Nakanishi, 2 Tomomi Nakakogawa, 2 Teruki Matsuoka, 2 Ryoma Matsuzaki, 2 Takashi Tanaka, 3 Harutoshi Sakakima 2 1 Department of Rehabilitation, Kyushu University of Nursing and Social Welfare, Kumamoto, Japan; 2 Department of Physical Therapy, School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan; 3 Department of Rehabilitation, Kumamoto Health Science University, Kumamoto, Japan Correspondence: Megumi Sumizono, Department of Rehabilitation, Kyushu University of Nursing and Social Welfare, 888 Tominoo, Tamana, Kumamoto, 865-0062, Japan, Tel/Fax +81 968-75-1931, Email Purpose: Pain disrupts the daily and social lives of patients with neuropathic pain. Effective treatment of neuropathic pain is difficult. Pharmacological treatments for neuropathic pain are limited, and 40– 60% of patients do not achieve even partial relief of their pain. This study created a chronic constriction injury (CCI) model in rats to examine the effects of regular exercise on neuropathic pain relief, elucidate the mechanism, and determine the effects of neuropathic pain in the hippocampus. Methods: CCI model rats were randomly divided into exercise (Ex) and no exercise (No-Ex) groups. Normal rats (Normal group) were used as controls. The Ex group exercised on a treadmill at 20 m/min for 30 min, 5 days per week for 5 weeks post-CCI. The 50% pain response threshold was assessed by mechanical stimulation. Using immunohistochemistry, we examined activation of glial cells (microglia and astrocytes) by CCR2 and TRAF6 expression in the spinal cord dorsal horn and DCX and PROX1 expression in the hippocampal dentate gyrus. Results: The 50% pain response threshold was significantly lower in the Ex than in the No-Ex group at 5 weeks post-CCI, indicating pain relief. In the spinal cord dorsal horn, IBA1, CCR2, and TRAF6 expression was markedly lower in the Ex group than in the No-Ex group at 3 weeks post-CCI. IBA1, GFAP, CCR2, and TRAF6 expression was markedly lower in the Ex group than in the No-Ex group at 5 weeks post-CCI. In the hippocampus, DCX, but not PROX1, expression was significantly higher in the Ex group than in the No-Ex group at 3 weeks post-CCI. At 5 weeks post-CCI, both DCX and PROX1 expression was markedly increased in the Ex group compared to the No-Ex group. Conclusion: Our findings suggest that regular exercise can improve the neuropathic pain-induced neurogenic dysfunction in the hippocampal dentate gyrus. Keywords: CCR2, hippocampal dentate gyrus, microglia, neurogenesis, spinal dorsal horn, TRAF6 The International Association for the Study of Pain defined pain as "An unpleasant sensory and emotional experience with actual or potential tissue damage, or described in terms of such damage" in 1979. However, almost 40 years thereafter, in 2020, pain was redefined as an unpleasant sensory and emotional experience related to or similar to actual or potential tissue damage. 1 An accurate classification of chronic neuropathic pain in the International Classification of Diseases (ICD)-11 is necessary to document the public health needs and therapeutic challenges associated with chronic neuropathic pain, which is a major contributor to the global burden of disease. Chronic pain is the most important cause of current and future morbidity-associated disability worldwide, with significant increases in both morbidity and disability loss each year. Its prevalence is considered to be constant or increasing, 2,3 at a population prevalence of 6.9‒10%. 4 The clinical manifestations of neuropathic pain include pathological pain states, such as spontaneous pain, burning pain, and hyperalgesia. Patients with neuropathic pain frequently present with abnormal sensation or hypersensitivity in the skin areas where peripheral nerves have been damaged. Neuropathic pain patients have more difficulties in daily life and social life due to their pain. However, neuropathic pain is very difficult to treat effectively. Pharmacological treatment of neuropathic pain is limited, with 40‒60% of patients failing to achieve even partial relief of their pain. 5–7 Various reports have addressed therapeutic effects and mechanisms of treatment in humans and animals, but many unclear issues remain. Neuropathic pain is caused by central or peripheral nerve damage. It has been reported that neuronal damage activates microglia and astrocytes in the dorsal horn of the spinal cord, causing pain through the production of inflammatory substances and abnormal nerve ce -Abstract Truncated-

Preconditioning by voluntary wheel running attenuates later neuropathic pain via Nrf2 antioxidant signaling in rats

Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury

Pulsed Radiofrequency to the Dorsal Root Ganglion or the Sciatic Nerve Reduces Neuropathic Pain Behavior, Decreases Peripheral Pro-Inflammatory Cytokines and Spinal Β-Catenin in Chronic Constriction Injury Rats

Voluntary exercise ameliorates neuropathic pain by suppressing calcitonin gene-related peptide and ionized calcium-binding adapter molecule 1 overexpression in the lumbar dorsal horns in response to injury to the cervical spinal cord

Voluntary running protects against neuromuscular dysfunction following hindlimb ischemia-reperfusion in mice

Effects of Pain Relief Through Minimal Exercise Intervention in a Rat Model of Neuropathic Pain

Short-duration physical activity prevents the development of activity-induced hyperalgesia through opioid and serotoninergic mechanisms

Voluntary running delays primary degeneration in rat retinas after partial optic nerve transection

Exercise as a promising alternative for sciatic nerve injury pain relief: a meta-analysis

Exercise-mediated improvements in painful neuropathy associated with prediabetes in mice

Voluntary wheel running attenuates urinary bladder hypersensitivity and dysfunction following neonatal maternal separation in female mice

Analgesic Effect of Exercise on Neuropathic Pain via Regulating the Complement Component 3 of Reactive Astrocytes

Mechanisms of Neuropathic Pain and Pain-Relieving Effects of Exercise Therapy in a Rat Neuropathic Pain Model

Role of brainstem serotonin in analgesia produced by low-intensity exercise on neuropathic pain after sciatic nerve injury in mice

Running Reduces Uncontrollable Stress-Evoked Serotonin and Potentiates Stress-Evoked Dopamine Concentrations in the Rat Dorsal Striatum

Exercise training modulates glutamic acid decarboxylase-65/67 expression through TrkB signaling to ameliorate neuropathic pain in rats with spinal cord injury

Treadmill running on neuropathic pain: via modulation of neuroinflammation

Swimming Training Attenuates Allodynia and Hyperalgesia Induced by Peripheral Nerve Injury in an Adult Male Rat Neuropathic Model: Effects on Irisin and GAD65

Exercise Preconditioning Reduces Neonatal Incision Surgery-Induced Enhanced Hyperalgesia Via Inhibition of P38 Mitogen-Activated Protein Kinase and IL-1β, TNF-α Release.

Physical exercise halts further functional decline in an animal model for Charcot–Marie–Tooth disease 1X at an advanced disease stage

Role of Exercise on Neuropathic Pain in Preclinical Models: Perspectives for Neuroglia